PROGENICS PHARMACEUTICALS NEVADA, INC.
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 08, 2010 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 677 Total Citation Count
- Nov 03, 1997 Earliest Filing
- 9 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6559158 Use of methylnaltrexone and related compounds to treat chronic opioid use side affectsSep 26, 00May 06, 03[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0087,472 USE OF METHYLNALTREXONE AND RELATED COMPOUND TO TREAT CONSTIPATION IN CHRONIC OPIOID USERSAbandonedJun 30, 09Apr 08, 10[A61K, A61P]
2009/0087,478 Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using ThemAbandonedDec 22, 05Apr 02, 09[A61K, C12P, C12N, C07K]
2004/0167,147 Oral use of methylnaltrexone and related compounds to induce laxation in chronic opioid usersAbandonedFeb 24, 04Aug 26, 04[A61K]
2004/0167,148 Oral use of methylnaltrexone and related compounds to treat constipation in chronic opioid usersAbandonedFeb 24, 04Aug 26, 04[A61K]
2004/0162,306 Use of methylnal trexone and related compounds to treat constipation in chronic opioid usersAbandonedFeb 12, 04Aug 19, 04[A61K]
2004/0162,307 Use of methylnaltrexone and related compounds to induce laxation in chronic opioid usersAbandonedFeb 12, 04Aug 19, 04[A61K]
2004/0162,308 Use of methylnaltrexone and related compounds for treatment of constipation caused by endogenous opioidsAbandonedFeb 12, 04Aug 19, 04[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.